| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 344 |
| 1 | METHOTREXATE | 327 |
| 2 | ADALIMUMAB | 323 |
| 3 | ETANERCEPT | 323 |
| 4 | TOCILIZUMAB | 323 |
| 5 | ABATACEPT | 316 |
| 6 | SULFASALAZINE | 316 |
| 7 | ANAKINRA | 312 |
| 8 | PREDNISONE | 303 |
| 9 | INFLIXIMAB | 302 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 3 | 0.0341 |
| 1 | HUMAN GROWTH HORMONE | 2 | 0.0286 |
| 2 | ANAKINRA | 312 | 0.0185 |
| 3 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 137 | 0.0056 |
| 4 | DACTINOMYCIN | 12 | 0.0054 |
| 5 | NAPROXEN SODIUM 220MG | 67 | 0.0049 |
| 6 | TRIAMCINOLONE ACETONIDE | 137 | 0.0043 |
| 7 | SULFASALAZINE | 316 | 0.0043 |
| 8 | ADALIMUMAB-FKJP | 189 | 0.0041 |
| 9 | ADALIMUMAB-AATY | 189 | 0.0038 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 356 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 327 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 326 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 323 |
| 4 | Aminosalicylate [EPC] | 316 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 316 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 312 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 253 |
| 8 | Vitamin C [EPC] | 85 |
| 9 | Vitamin B12 [EPC] | 83 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 312 | 0.0185 |
| 1 | Actinomycin [EPC] | 12 | 0.0054 |
| 2 | Aminosalicylate [EPC] | 316 | 0.0031 |
| 3 | Human Immunoglobulin G [EPC] | 63 | 0.0030 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 323 | 0.0023 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 316 | 0.0023 |
| 6 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 7 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 327 | 0.0007 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 326 | 0.0003 |